Month 2 is where mental preparation matters most
[1] [2] Some patients have reported experiencing sore throat symptoms whilst taking Saxenda, though these reports should be considered alongside the background rate of throat symptoms in the general population
However, what makes Mounjaro unique is that it not only acts as a GLP-1 receptor agonist but also targets the GIP receptor, making it a dual-action treatment
If flu-like symptoms persist beyond the expected titration phase without improvement, or worsen over time, this warrants medical review to exclude other causes and consider whether the medication is appropriate for continued use
On the other hand, the adverse events of GLP-1 drugs have been extensively characterized from large randomized trials with placebo controls and, in the United States, from reports derived from 12% of Americans who are currently taking these drugs
Ultimately, the guiding principle is consistency